• Ven. Ott 18th, 2024

Farmacologia

  • Home
  • Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Colorized scanning electron micrograph of mpox virus particles (blue) on the surface of infected VERO E6 cells (pink). NIAID A dose-sparing intradermal mpox vaccination regimen was safe and generated an…

A vaccine to fight antibiotic resistance

Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million people worldwide in 2019, according…

TUMORE MAMMARIO: APPROCCIO “RISK ADAPTED” PUO’ MIGLIORARE LE CURE MEDICHE

È stata recentemente pubblicata sulla prestigiosa rivista della Società Americana di Oncologia Clinica – il Journal of Clinical Oncology – la posizione di alcuni dei maggiori esperti oncologi internazionali circa…

How does aspirin help prevent colorectal cancer development and progression?

Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but the mechanisms involved have been unclear. New research has revealed that aspirin may…

FARMACIA SERVIZI, FNOMCEO: REGOLE UNICHE PER TUTTI I CITTADINI

Regole uniche per tutti i cittadini, al fine di assicurare l’uguaglianza nell’accesso alle cure, la qualità e l’appropriatezza delle prestazioni. È quanto chiede il Presidente della Fnomceo, la Federazione nazionale…

Tg Salutedomani Tv: AI and Parkinson’s disease, exercises after heart event, Covid and asthma in children

AI SPEEDS UP DRUG DESIGN FOR PARKINSON’S BY TEN-FOLD Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments. The researchers, from the University of…

Gene therapy is halting cancer. Can it work against brain tumors?

Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology. A type of gene therapy called CAR-T…

INFARTO, IN LIGURIA SI STUDIANO NUOVE STRATEGIE

La Liguria metterà a punto una serie di strategie per ridurre gli infarti e altri eventi cardiovascolari. Alisa, l’azienda ligure sanitaria, è pronta a elaborare nuove raccomandazioni per promuovere il…

mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…

Tumore, MD Anderson e CureVac insieme per il vaccino a mRna

L’Università del Texas MD Anderson Cancer Center e CureVac N.V. hanno annunciato oggi un accordo di co-sviluppo e licenza per sviluppare nuovi vaccini contro il cancro a base di mRNA.…